Roche’s big-hope breast cancer drug fails in crucial first-line trial
罗氏寄予厚望的乳腺癌重磅药物在关键一线试验中失利

Roche’s breast cancer pill, which the company recently said had the potential to become its biggest-ever selling drug, has failed in what is arguably its most important Phase 3 trial.
罗氏公司日前称有望成为其史上最畅销药物的乳腺癌口服药，在一项可谓最重要的三期临床试验中告败。